N Krug, LM Teran, AE Redington, C Gratziou, S Montefort, R Polosa, H Brewster, PH Howarth, ST Holgate, AJ Frew and MP Carroll
Immunopharmacology Group, University Medicine, Southampton General Hospital, United Kingdom.

Local endobronchial allergen challenge is being increasingly used to investigate the role of allergic inflammation in asthma. However, little information is available about the safety of this procedure and the changes induced in airway physiology. BAL and biopsy were performed at 10 min and at 4 to 6 h, or 24 h after segmental allergen challenge in 49 patients with atopic asthma. Two hours after challenge, FEV1 was reduced from 97.6 +/- 13.9 (mean +/- SD) to 83.4 +/- 21.7% predicted. FEV1 remained reduced at 4 to 6 h (87.7 +/- 20.4%), but it had nearly returned to baseline by 24 h (93.2 +/- 14.0%). When endobronchial challenge was combined with BAL and biopsy, the initial fall in FEV1 was slightly greater (from 101.8 +/- 14.2 to 78.5 +/- 13.6%). Bronchial responsiveness to methacholine was measured in 10 subjects, and it showed a twofold increase 24 h after local challenge and lavage. Significant changes in FEV1 and methacholine PC20 were still detectable 72 h after challenge. Widespread wheezing occurred in 29% of the subjects, but none of the them had to be admitted to hospital. We conclude that local endobronchial allergen challenge, although producing measurable changes in airway physiology, is in general well tolerated and is an acceptable method to investigate airway pathophysiologic processes in patients with mild to moderate asthma.

This article has been cited by other articles:

				W. W. Busse, A. Wanner, K. Adams, H. Y. Reynolds, M. Castro, B. Chowdhury, M. Kraft, R. J. Levine, S. P. Peters, and E. J. Sullivan Investigative Bronchoprovocation and Bronchoscopy in Airway Diseases Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 807 - 816. [Abstract] [Full Text] [PDF]

				N. Krug, V. J. Erpenbeck, K. Balke, J. Petschallies, T. Tschernig, J. M. Hohlfeld, and H. Fabel Cytokine Profile of Bronchoalveolar Lavage-Derived CD4+, CD8+, and gamma delta T Cells in People with Asthma after Segmental Allergen Challenge Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 125 - 131. [Abstract] [Full Text] [PDF]

				S. Uhlig, A. Wohlsen, F. Brasch, C. Y. Seow, and P. D. Pare Can airways close completely? J Appl Physiol, December 1, 2000; 89(6): 2521 - 2522. [Full Text] [PDF]

				N. KRUG, W. W. CRUIKSHANK, T. TSCHERNIG, V. J. ERPENBECK, K. BALKE, J. M. HOHLFELD, D. M. CENTER, and H. FABEL Interleukin 16 and T-cell Chemoattractant Activity in Bronchoalveolar Lavage 24 Hours after Allergen Challenge in Asthma Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 105 - 111. [Abstract] [Full Text]

				I. M. NDUKWU, E. T. NAURECKAS, C. MAXWELL, M. WALDMAN, and A. R. LEFF Relationship of Cellular Transmigration and Airway Response after Allergen Challenge Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1516 - 1524. [Abstract] [Full Text]

				J. M. HOHLFELD, K. AHLF, G. ENHORNING, K. BALKE, V. J. ERPENBECK, J. PETSCHALLIES, H. G. HOYMANN, H. FABEL, and N. KRUG Dysfunction of Pulmonary Surfactant in Asthmatics after Segmental Allergen Challenge Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1803 - 1809. [Abstract] [Full Text]

				N. N. JARJOUR, S. P. PETERS, R. DJUKANOVIC, and W. J. CALHOUN Investigative Use of Bronchoscopy in Asthma Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 692 - 697. [Full Text] [PDF]

				S. T. HOLGATE, K. S. BODEY, A. JANEZIC, A. J. FREW, A. P. KAPLAN, and L. M. TERAN Release of RANTES, MIP-1alpha , and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1377 - 1383. [Abstract] [Full Text]

				A. E. REDINGTON, J. MADDEN, A. J. FREW, R. DJUKANOVIC, W. R. ROCHE, S. T. HOLGATE, and P. H. HOWARTH Transforming Growth Factor-beta 1 in Asthma . Measurement in Bronchoalveolar Lavage Fluid Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 642 - 647. [Abstract] [Full Text]